Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 6 member 14 (SLC6A14), also known as the ATB0,+ transporter system, is a Na+/Cl--coupled, highly concentrative amino acid transporter. It is unique in its ability to transport 18 of the 20 proteinogenic amino acids, excluding only the acidic amino acids aspartate and glutamate. SLC6A14 is expressed at very low levels in normal tissues but is highly upregulated in various solid tumors, including colorectal, pancreatic, cervical, and estrogen receptor-positive breast cancers. In these malignancies, it serves as a critical nutrient hub, importing essential amino acids and glutamine to fuel rapid cell proliferation, activate the oncogenic mTOR signaling pathway, and support metabolic reprogramming. Consequently, SLC6A14 is an attractive therapeutic target for cancer therapy, where its pharmacological blockade (e.g., using alpha-methyl-L-tryptophan) induces amino acid starvation, inhibits mTOR, and triggers apoptosis in tumor cells. Additionally, due to its broad substrate specificity and high concentrative capacity, SLC6A14 is being utilized as a drug delivery system to shuttle amino acid-conjugated prodrugs directly into target cells.
Inhibition of amino acid transport via blockade of the substrate-binding site, leading to intracellular amino acid starvation, suppression of mTOR signaling, and induction of autophagy and apoptosis. It also acts as a delivery channel for amino acid-conjugated prodrugs to enhance intracellular drug accumulation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 6 member 14 (SLC6A14).